Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-31 | New | $3,055,500 | $3,055,500 | Equity Only | 06b | SEC link |
| 2023-01-09 | New | $12,759,950 | $12,759,950 | Equity Only | 06b | SEC link |
| 2022-09-21 | Amended | $4,000,000 | $950,000 | Other | 06b | SEC link |
| 2022-04-15 | New | $3,050,000 | $3,050,000 | Other | 06b | SEC link |
| 2020-08-26 | New | $4,000,000 | $4,000,000 | Equity Only | 06b | SEC link |
| 2019-07-11 | New | $5,772,023 | $5,772,023 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Brett Berman | Director, Executive |
| Dan Bradbury | Director |
| Kim Kamdar | Director |
| Magda Marquet | Director |
| Jean Pierre Million | Director |
| Jean Pierre Millon | Director |
| Quyen Nguyen | Director, Executive |
| Kaveri Parker | Executive |
| James Schmidt | Executive |